Not to be a dripping tap of negativity but let's recap recent progress. The hopes and dreams needs to be offset with a little reality:No word or update on any progress on promised Indonesian formal agreement.Another vague and misleading trial finished with no plasma information and concerning vocab choices calling into question success or broader use.Announcement of a clinical trial with a small public and rural health service.Continued high wages and dwindling capital.Stagnant share price.
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete, page-32
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |